Transaction DateRecipientSharesTypePriceValue
2nd June 2020Michael Sardano1,483Payment by withholding$3.05$4,523.15
2nd June 2020Javier Rampolla1,186Payment by withholding$3.05$3,617.30
2nd June 2019Michael Sardano1,948Payment by withholding$5.59$10,889.32
2nd June 2019Arthur Levine14,628Payment by withholding$5.59$81,770.52
22nd March 2019Kalman Fishman173Open or private sale$7.50$1,297.50
22nd March 2019Stephen Brad Cohen595Open or private sale$7.50$4,462.50
22nd March 2019Richard Golin492Open or private sale$7.50$3,690.00
21st March 2019Richard Golin509Open or private sale$7.50$3,817.50
20th March 2019Richard Golin5,943Open or private sale$7.56$44,929.08
Sensus Healthcare
Sensus Healthcare logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


Sensus Healthcare's SRT-100 is a photon x-ray low energy superficial radiotherapy system. It provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions.


Ticker: SRTS
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1494891
Employees: 53
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals